Personalized treatment strategies are central to managing lung cancer brain metastases, enhancing patient outcomes.
Targeted therapies and immunotherapies offer effective, less invasive alternatives to traditional treatments.
The roles of stereotactic radiosurgery and whole-brain radiation therapy are evolving with new systemic treatments.
Multidisciplinary approaches are crucial, requiring collaboration among oncologists, radiologists, and neurosurgeons.
SHOW MORE
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.